Marcello Allegretti

6.5k total citations
116 papers, 3.6k citations indexed

About

Marcello Allegretti is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Marcello Allegretti has authored 116 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 35 papers in Immunology and 34 papers in Oncology. Recurrent topics in Marcello Allegretti's work include Chemokine receptors and signaling (20 papers), Immune Response and Inflammation (12 papers) and Corneal Surgery and Treatments (8 papers). Marcello Allegretti is often cited by papers focused on Chemokine receptors and signaling (20 papers), Immune Response and Inflammation (12 papers) and Corneal Surgery and Treatments (8 papers). Marcello Allegretti collaborates with scholars based in Italy, United States and Brazil. Marcello Allegretti's co-authors include Riccardo Bertini, Laura Brandolini, Maria Candida Cesta, Cinzia Bizzarri, Flavio Mantelli, Andrea R. Beccari, Annamaria Cimini, Mauro Martins Teixeira, Michele d’Angelo and Andrea Aramini and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Marcello Allegretti

111 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcello Allegretti Italy 34 1.2k 988 909 353 318 116 3.6k
John M. Sanders United States 37 835 0.7× 501 0.5× 1.6k 1.7× 251 0.7× 402 1.3× 71 4.0k
Roberto Bei Italy 40 976 0.8× 1.0k 1.0× 2.0k 2.2× 325 0.9× 121 0.4× 154 5.1k
Yahiya Y. Syed New Zealand 36 420 0.3× 1.0k 1.0× 1.3k 1.4× 216 0.6× 242 0.8× 107 3.8k
Hannah A. Blair New Zealand 34 520 0.4× 539 0.5× 928 1.0× 251 0.7× 189 0.6× 138 3.3k
Carole Nicco France 37 1.3k 1.1× 612 0.6× 2.2k 2.4× 249 0.7× 316 1.0× 107 5.2k
Giuseppe Nocentini Italy 36 2.5k 2.1× 850 0.9× 931 1.0× 416 1.2× 165 0.5× 120 4.4k
Bernard Weill France 41 1.5k 1.2× 645 0.7× 1.6k 1.7× 374 1.1× 192 0.6× 132 5.5k
Akihiro Sekine Japan 31 792 0.7× 568 0.6× 1.5k 1.7× 325 0.9× 375 1.2× 103 4.4k
Laurent Audoly United States 38 949 0.8× 634 0.6× 1.8k 1.9× 691 2.0× 326 1.0× 69 5.9k
Maria Cristina Pagliacci Italy 17 1.3k 1.1× 927 0.9× 2.7k 2.9× 261 0.7× 244 0.8× 31 5.3k

Countries citing papers authored by Marcello Allegretti

Since Specialization
Citations

This map shows the geographic impact of Marcello Allegretti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcello Allegretti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcello Allegretti more than expected).

Fields of papers citing papers by Marcello Allegretti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcello Allegretti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcello Allegretti. The network helps show where Marcello Allegretti may publish in the future.

Co-authorship network of co-authors of Marcello Allegretti

This figure shows the co-authorship network connecting the top 25 collaborators of Marcello Allegretti. A scholar is included among the top collaborators of Marcello Allegretti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcello Allegretti. Marcello Allegretti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Çarçak, Nihan, Canan Ulusoy, Erdem Tüzün, et al.. (2025). Reparixin as a Potential Antiepileptogenic Agent: Modulation of the CXCL1–CXCR1/2 Axis and Seizure Activity in a Kindling Rat Model of Temporal Lobe Epilepsy. International Journal of Molecular Sciences. 26(7). 2831–2831.
2.
Cesta, Maria Candida, et al.. (2024). AEBS inhibition in macrophages: Augmenting reality for SERMs repurposing against infections. Biochemical Pharmacology. 229. 116544–116544. 1 indexed citations
3.
Castelli, Vanessa, et al.. (2024). TNFα-CXCR1/2 partners in crime in insulin resistance conditions. Cell Death Discovery. 10(1). 486–486. 5 indexed citations
4.
Castelli, Vanessa, Michele d’Angelo, Francesca Zazzeroni, et al.. (2023). Intranasal delivery of NGF rescues hearing impairment in aged SAMP8 mice. Cell Death and Disease. 14(9). 605–605. 4 indexed citations
5.
Grasselli, Chiara, Silvia Bombelli, Vittoria D’Esposito, et al.. (2023). The therapeutic potential of an allosteric non‐competitive CXCR1/2 antagonist for diabetic nephropathy. Diabetes/Metabolism Research and Reviews. 39(7). e3694–e3694. 4 indexed citations
6.
d’Angelo, Michele, Laura Brandolini, Mariano Catanesi, et al.. (2023). Differential Effects of Nonsteroidal Anti-Inflammatory Drugs in an In Vitro Model of Human Leaky Gut. Cells. 12(5). 728–728. 8 indexed citations
7.
Canepa, Paolo, Claudio Canale, Ornella Cavalleri, et al.. (2023). Adsorption of the rhNGF Protein on Polypropylene with Different Grades of Copolymerization. Materials. 16(5). 2076–2076. 2 indexed citations
8.
Piemonti, Lorenzo, Bart Keymeulen, Pieter Gillard, et al.. (2022). Ladarixin, an inhibitor of the interleukin‐8 receptors CXCR1 and CXCR2 , in new‐onset type 1 diabetes: A multicentre, randomized, double‐blind, placebo‐controlled trial. Diabetes Obesity and Metabolism. 24(9). 1840–1849. 36 indexed citations
9.
Piro, Geny, Carmine Carbone, Antonio Agostini, et al.. (2022). CXCR1/2 dual-inhibitor ladarixin reduces tumour burden and promotes immunotherapy response in pancreatic cancer. British Journal of Cancer. 128(2). 331–341. 19 indexed citations
10.
Castelli, Vanessa, Laura Brandolini, Michele d’Angelo, et al.. (2021). CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling. Cells. 10(9). 2324–2324. 13 indexed citations
11.
Mantuano, Paola, Gianluca Bianchini, Elena Conte, et al.. (2021). BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading. Pharmacological Research. 171. 105798–105798. 19 indexed citations
12.
Metzemaekers, Mieke, Anneleen Mortier, Daiane Boff, et al.. (2021). Endogenous modification of the chemoattractant CXCL5 alters receptor usage and enhances its activity toward neutrophils and monocytes. Science Signaling. 14(673). 13 indexed citations
13.
Castelli, Vanessa, Antonella Paladini, Michele d’Angelo, et al.. (2021). Taurine and oxidative stress in retinal health and disease. CNS Neuroscience & Therapeutics. 27(4). 403–412. 61 indexed citations
14.
Catanesi, Mariano, Laura Brandolini, Michele d’Angelo, et al.. (2021). S-Carboxymethyl Cysteine Protects against Oxidative Stress and Mitochondrial Impairment in a Parkinson’s Disease In Vitro Model. Biomedicines. 9(10). 1467–1467. 11 indexed citations
15.
Brandolini, Laura, Michele d’Angelo, Andrea Antonosante, Annamaria Cimini, & Marcello Allegretti. (2019). Chemokine Signaling in Chemotherapy-Induced Neuropathic Pain. International Journal of Molecular Sciences. 20(12). 2904–2904. 77 indexed citations
16.
Sacchetti, Marta, Alessandro Lambìase, Doreen Schmidl, et al.. (2019). Effect of recombinant human nerve growth factor eye drops in patients with dry eye: a phase IIa, open label, multiple-dose study. British Journal of Ophthalmology. bjophthalmol–2018. 50 indexed citations
17.
Alfaro, Carlos, Álvaro Teijeira, Carmen Oñate, et al.. (2016). Tumor-Produced Interleukin-8 Attracts Human Myeloid-Derived Suppressor Cells and Elicits Extrusion of Neutrophil Extracellular Traps (NETs). Clinical Cancer Research. 22(15). 3924–3936. 316 indexed citations
18.
Lopes, Alexandre H., Laura Brandolini, Andrea Aramini, et al.. (2015). DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain. Pharmacological Research. 103. 69–79. 27 indexed citations
19.
Cimini, Annamaria, Laura Brandolini, Roberta Gentile, et al.. (2014). Gastroprotective Effects of L‐Lysine Salification of Ketoprofen in Ethanol‐Injured Gastric Mucosa. Journal of Cellular Physiology. 230(4). 813–820. 30 indexed citations
20.
Mascagni, Paolo, Leda Biordi, Stefano Martinotti, et al.. (2000). R- and S-isomers of nonsteroidal anti-inflammatory drugs differentially regulate cytokine production.. PubMed. 11(2). 185–92. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John M. Sanders Breakdown of academic impact, for papers by Roberto Bei Breakdown of academic impact, for papers by Yahiya Y. Syed Breakdown of academic impact, for papers by Hannah A. Blair Breakdown of academic impact, for papers by Carole Nicco Breakdown of academic impact, for papers by Giuseppe Nocentini Breakdown of academic impact, for papers by Bernard Weill Breakdown of academic impact, for papers by Akihiro Sekine Breakdown of academic impact, for papers by Laurent Audoly Breakdown of academic impact, for papers by Maria Cristina Pagliacci
Rankless by CCL
2026